Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Prout

Showing results (111-120 of 202) with videos related to

Pageof 21
Sort By:
Cancer Research|November 1, 1988
Photodynamic effect in an experimental bladder tumor treated with intratumor injection of hematoporphyrin derivativeC W Lin, T Amano, A R Rutledge, et al.
The Journal of Urology|November 1, 1983
Invasive bladder cancer: tumor configuration, lymphatic invasion and survivalN M Heney, K Proppe, G R Prout, et al.
Cancer|November 15, 1985
Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in "surveillance only" protocolsN Moriyama, J J Daly, M A Keating, et al.
The Journal of Urology|March 1, 1981
The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladderW W Koontz, G R Prout, W Smith, et al.
The Journal of Urology|March 1, 1984
Cystoscopic fluorescence detector for photodetection of bladder carcinoma with hematoporphyrin derivativeC W Lin, D A Bellnier, G R Prout, et al.
Surgical Forum|January 1, 1978
Galactosyl transferase in benign and neoplastic human bladder mucosaK Hagen-Cook, G R Prout, G M Plotkin, et al.
The Journal of Urology|May 1, 1978
Altered androgen metabolism in metastatic prostate cancerB Kliman, G R Prout, R A Maclaughlin, et al.
Cancer Genetics and Cytogenetics|June 1, 1988
New cytogenetic subtype of renal tumorsP Dal Cin, A A Sandberg, R Huben, et al.
International Journal of Nuclear Medicine and Biology|January 1, 1985
A simplified technique for quantifying 24-h whole body retention of 99mTc-labeled methylene diphosphonate (MDP)F P Castronovo, K A McKusick, J Dann, et al.
The Urologic Clinics of North America|August 11, 1991
Interval report of a phase I-II study utilizing multiple modalities in the treatment of invasive bladder cancer. A bladder-sparing trialG R Prout, W U Shipley, D S Kaufman, et al.
Pageof 21

Showing results (111-120 of 202) with videos related to

Sort By:
Pageof 21
Cancer Research|November 1, 1988
Photodynamic effect in an experimental bladder tumor treated with intratumor injection of hematoporphyrin derivativeC W Lin, T Amano, A R Rutledge, et al.
The Journal of Urology|November 1, 1983
Invasive bladder cancer: tumor configuration, lymphatic invasion and survivalN M Heney, K Proppe, G R Prout, et al.
Cancer|November 15, 1985
Vascular invasion as a prognosticator of metastatic disease in nonseminomatous germ cell tumors of the testis. Importance in "surveillance only" protocolsN Moriyama, J J Daly, M A Keating, et al.
The Journal of Urology|March 1, 1981
The use of intravesical thio-tepa in the management of non-invasive carcinoma of the bladderW W Koontz, G R Prout, W Smith, et al.
The Journal of Urology|March 1, 1984
Cystoscopic fluorescence detector for photodetection of bladder carcinoma with hematoporphyrin derivativeC W Lin, D A Bellnier, G R Prout, et al.
Surgical Forum|January 1, 1978
Galactosyl transferase in benign and neoplastic human bladder mucosaK Hagen-Cook, G R Prout, G M Plotkin, et al.
The Journal of Urology|May 1, 1978
Altered androgen metabolism in metastatic prostate cancerB Kliman, G R Prout, R A Maclaughlin, et al.
Cancer Genetics and Cytogenetics|June 1, 1988
New cytogenetic subtype of renal tumorsP Dal Cin, A A Sandberg, R Huben, et al.
International Journal of Nuclear Medicine and Biology|January 1, 1985
A simplified technique for quantifying 24-h whole body retention of 99mTc-labeled methylene diphosphonate (MDP)F P Castronovo, K A McKusick, J Dann, et al.
The Urologic Clinics of North America|August 11, 1991
Interval report of a phase I-II study utilizing multiple modalities in the treatment of invasive bladder cancer. A bladder-sparing trialG R Prout, W U Shipley, D S Kaufman, et al.
Pageof 21